Gemphire Therapeutics News

Thinking about buying stock in Progenity, Neurobo Pharmaceuticals, Vistra Corp, Plug Power, or Tata Motors?

PR NewswireOct 13, 2021 08:31

BRIEF-Gemphire Therapeutics Says Merger With Neurobo Pharmaceuticals Expected To Close On Dec 30

路透社Dec 31, 2019 03:34

Gemphire Therapeutics Announces Expected Closing Date Of Merger With NeuroBo Pharmaceuticals >GEMP

道琼斯Dec 31, 2019 00:07

Press Release: Gemphire Therapeutics Announces Stockholder Approval of Proposals Required for Merger with NeuroBo Pharmaceuticals

道琼斯Dec 6, 2019 21:42

Gemphire Therapeutics Files 8K - Changes To Hldr Rights >GEMP

道琼斯Oct 30, 2019 18:20

Gemphire Therapeutics Inc, Inst Holders, 3Q 2019 (GEMP)

道琼斯Oct 20, 2019 15:47

BRIEF-Gemphire Therapeutics Reports Q2 Loss Per Share $0.20

路透社Aug 9, 2019 20:14

Gemphire Therapeutics Inc盘中异动 急速拉升5.60%

智能写手Jul 31, 2019 23:08

Gemphire Therapeutics Inc盘中异动 早盘急速下跌7.32%报0.760美元

智能写手Jul 29, 2019 21:38

Gemphire Therapeutics Inc盘中异动 急速下跌6.81%

智能写手Jul 26, 2019 21:37

Gemphire-Beijing SL Pharmaceutical Partnership Expected to Provide Upfront Gross Payment of $2.5M to Gemphire >GEMP

道琼斯Jul 26, 2019 18:07

Can Fite Biofarma Ltd's intraday change early trading quick dive 6.57% to $2.70

At 23:00 on July 25, 2019, Beijing time, Can Fite Biofarma Ltd (CanF.us) shares fluctuated, and the stock price quickly dived 6.57%. As of press release, the stock reported $2.70 per share, with a trading volume of 267.33 million shares, a turnover rate of 0.80%, and an amplitude of 6.92%. According to the latest 2019-03-31 data, the stock achieved operating income of $300,186.11, net profit of -$1.84 million, earnings per share of -$1.23, gross profit--, price-earnings ratio of -0.56 times. Agency raters

智能写手Jul 25, 2019 23:00

Gemphire Therapeutics, NeuroBo Pharmaceuticals to Merge >GEMP

道琼斯Jul 25, 2019 04:26

Gemphire Therapeutics: John L. Brooks III Will Be Appointed to Serve as the Post-Merger Combined Company's Pres and CEO >GEMP

道琼斯Jul 25, 2019 04:03

Press Release: Gemphire Therapeutics and NeuroBo -2-

道琼斯Jul 25, 2019 04:03

Gemphire Therapeutics and NeuroBo Pharmaceuticals Announce Merger Agreement to Advance a Neurodegenerative Disease Co >GEMP

道琼斯Jul 25, 2019 04:01

Gemphire Therapeutics Inc盘中异动 股价大跌5.41%

智能写手Jul 22, 2019 21:48

Gemphire Therapeutics Inc, Inst Holders, 2Q 2019 (GEMP)

道琼斯Jul 20, 2019 15:44

Gemphire Therapeutics Inc盘中异动 大幅下跌9.23%

智能写手Jul 18, 2019 03:27

Gemphire Therapeutics Inc盘中异动 股价大涨5.56%

智能写手Jul 16, 2019 02:19